Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Heart Foundation Health Promotion Research Group, based in the Nuffield Department of Population Health, has been officially designated as a World Health Organization (WHO) Collaborating Centre.

The new centre will be known as the British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention. The launch of this centre will be held on the Monday the 28th of April from 10.00 am to 12.00 at the Richard Doll Building, Old Road Campus in Oxford.

The overall aim of the centre is to carry out research of the highest methodological quality that has the greatest possible influence on public health policy and practice, as it relates to the primary prevention of non-communicable disease (NCD).

The centre has five main research themes. They are:

  • Diet and nutrition
  • Physical activity
  • Obesity
  • Environmental sustainability
  • Cardiovascular disease epidemiology

As a WHO Collaborating Centre it will be:

  • Working with WHO in capacity building for population level approaches for NCD prevention
  • Contributing to WHO's work in the development of guidelines/manuals on population level NCD prevention.
  • Assisting WHO to develop methods for evaluating population level NCD prevention programmes including training programmes.
  • Providing WHO with statistical analysis and systematic reviews related to population level NCD prevention.

The United Nations meeting of the on the prevention and control of NCDs in September 2011 has resulted in a greater focus on population approaches to prevent NCDs, such as cardiovascular disease, cancer, diabetes and chronic respiratory disease.

Many countries are now considering and implementing population approaches to NCD prevention which include measures such as taxes on tobacco, alcohol and unhealthy foods, , bans on the advertising  of such products, providing better information about unhealthy products, and the provision of better facilities for active travel and recreation involving physical activity.

Evidence on the effectiveness of population approaches to NCD prevention is vitally important to make inform governments and other policy makers concerned about the rising burden of NCDs. This new centre will play a leading role in providing such evidence and help to build the capacity locally and internationally for population approaches for NCD prevention., 

For enquiries relating to the WHO Collaborating Centre’s activities please contact:

Dr Mike Rayner (mike.rayner@dph.ox.ac.uk) or Dr Kremlin Wickramasinghe (kremlin.wickramasinghe@dph.ox.ac.uk)

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.